Output is developing Biologically-Aware Generative AI that constructs Large Biological Models to analyze complex biological systems. This technology enables the generation of novel medicines by effectively processing high-dimensional biological data, enhancing disease diagnosis, treatment, and prevention.
Funding
Funding not disclosed
Founders
Product
Problem
Analyzing complex biological systems to develop new medicines is challenging due to the high-dimensional, non-linear, and fragmented nature of biological data. Traditional methods struggle to effectively process and interpret this data, hindering advancements in disease diagnosis, treatment, and prevention.
Solution
Output is developing Biologically-Aware Generative AI to construct Large Biological Models capable of analyzing complex biological systems. This technology enables the generation of novel medicines by effectively processing high-dimensional biological data. Their generative AI architecture is designed to handle the complexities inherent in biological systems, transforming the way diseases are diagnosed, treated, and prevented. By teaching generative AI the language of biology, Output aims to advance healthcare through AI-driven insights.
Target Audience
The primary audience includes pharmaceutical companies, biotech startups, and research institutions seeking to accelerate drug discovery and improve disease management through advanced AI technologies.
Features
- Biologically-Aware Generative AI designed to understand complex biological systems.
- Large Biological Models capable of processing high-dimensional biological data.
- AI architecture tailored for the non-linear and fragmented nature of biological data.
- Capabilities for generating novel medicines.
- Applications in disease diagnosis, treatment, and prevention.